Arcutis Biotherapeutics Stock (NASDAQ: ARQT) stock price, news, charts, stock research, profile.
Open | $9.670 |
Close | $9.910 |
Volume / Avg. | 3.724M / 5.262M |
Day Range | 9.610 - 10.020 |
52 Wk Range | 1.760 - 15.400 |
Market Cap | $1.139B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 17.78% |
Days to Cover | 3.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arcutis Biotherapeutics (NASDAQ: ARQT) through any online brokerage.
Other companies in Arcutis Biotherapeutics’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).
The latest price target for Arcutis Biotherapeutics (NASDAQ: ARQT) was reported by Goldman Sachs on Wednesday, February 28, 2024. The analyst firm set a price target for 11.00 expecting ARQT to rise to within 12 months (a possible 11.00% upside). 28 analyst firms have reported ratings in the last year.
The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $9.91 last updated Today at March 28, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Arcutis Biotherapeutics.
Arcutis Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Arcutis Biotherapeutics.
Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.